Trials / Unknown
UnknownNCT01152892
Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study
Risk Stratification in End Stage Renal Disease (ISAR)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the use of non-invasive markers of the autonomic function and micro- and macrocirculation to predict mortality and cardiovascular end points in end-stage renal disease patients. Furthermore we aim at getting new insight into the insufficiently understood pathophysiology leading to excessively high cardiovascular and non-cardiovascular mortality in dialysis patients.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2019-05-01
- Completion
- 2020-05-01
- First posted
- 2010-06-29
- Last updated
- 2016-01-26
Locations
17 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01152892. Inclusion in this directory is not an endorsement.